ERBB2 and breast carcinoma: Indeed, loss of CdGAP in ErbB2-expressing mouse mammary tumor cells and in human breast cancer MDA-MB-231 cells resulted in a decrease of SNAIL1 and ZEB2 concomitantly with an increase of E-cadherin and reinstatement of cellular adherens junctions7.